Inhibition of K+ channel activity in human pulmonary artery smooth muscle cells by serum from patients with pulmonary hypertension secondary to congenital heart disease

Pediatric Research

Volumn 50, Issue 1 I, 2001, Pages 23-28

  Limsuwan, A ^a   Platoshyn, O ^a   Yu, Y ^a   Rubin, L J ^a   Rothman, A ^a   Yuan, J X J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GROWTH FACTOR; POTASSIUM CHANNEL; POTASSIUM ION;

AMPLITUDE MODULATION; ARTERY MUSCLE; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; INFANT; LUNG VASOCONSTRICTION; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SERUM; VOLTAGE CLAMP;

EID: 0034985090     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200107000-00007     Document Type: Article

References (31)

1. Pathophysiology of pulmonary hypertension
2. Pulmonary vascular disease with congenital heart lesion: Pathologic features and causes
3. Therapy for pulmonary hypertension
4. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension
5. + channel gene transcription in primary pulmonary hypertension
6. + current that is active at resting potential in rabbit pulmonary artery smooth muscle cells
7. 2+]i in pulmonary arterial myocytes
8. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction
9. Calcium channels, potassium channels, and voltage-dependence of arterial smooth muscle tone
10. Signal transduction and regulation in smooth muscle
11. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells
12. Potassium currents in cultured human pulmonary arterial smooth muscle cells
13. Calcium signaling and cell proliferation
14. Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation
15. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches
16. Increased interleukin-1 and interleukin-6 serum concentration in severe primary pulmonary hypertension
17. Increased plasma serotonin in primary pulmonary hypertension
18. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects: Evidence for increased production of endothelin in pulmonary circulation
19. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome
20. Elevated plasma endothelin-1 and cytokine levels in children with severe acute respiratory distress syndrome
21. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow
22. Plasma thromboxane B2 concentration in patients with ventricular septal defect and pulmonary hypertension
23. Pulmonary blood flow alters nitric oxide production in patients undergoing device closure of atrial septal defects
24. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension
25. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
26. Source of nuclear calcium signals
27. 2+ stores and cell responsiveness
28. Calcium, calmodulin and cell cycle regulation
29. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture
30. Activation of MAP kinases by calcium-dependent and calcium-independent pathways: Stimulation by thapsigargin and epidermal growth factor
31. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB